M.B. Tyers

6.3k total citations · 1 hit paper
73 papers, 5.3k citations indexed

About

M.B. Tyers is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, M.B. Tyers has authored 73 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 36 papers in Molecular Biology and 18 papers in Physiology. Recurrent topics in M.B. Tyers's work include Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (21 papers) and Pharmacological Receptor Mechanisms and Effects (20 papers). M.B. Tyers is often cited by papers focused on Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (21 papers) and Pharmacological Receptor Mechanisms and Effects (20 papers). M.B. Tyers collaborates with scholars based in United Kingdom, United States and Poland. M.B. Tyers's co-authors include Gavin J. Kilpatrick, R.J. Naylor, B. Costall, Brian Jones, Ann G. Hayes, S.J. Ireland, A.M. Domeney, M. Skingle, M.E. Kelly and K T Bunce and has published in prestigious journals such as Nature, Brain and Trends in Neurosciences.

In The Last Decade

M.B. Tyers

71 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

1987 746 citations Gavin J. Kilpatrick, Brian Jones et al. Nature profile →

Peers

Countries citing papers authored by M.B. Tyers

Since Specialization

Citations

This map shows the geographic impact of M.B. Tyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.B. Tyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.B. Tyers more than expected).

Fields of papers citing papers by M.B. Tyers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.B. Tyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.B. Tyers. The network helps show where M.B. Tyers may publish in the future.

Co-authorship network of co-authors of M.B. Tyers

This figure shows the co-authorship network connecting the top 25 collaborators of M.B. Tyers. A scholar is included among the top collaborators of M.B. Tyers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.B. Tyers. M.B. Tyers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box 1993 ·European Journal of Pharmacology ·Sharon C. Stratton, I.J.M. Beresford, (unknown), (unknown), R.M. Hagan, M.B. Tyers	35
2	Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse 1993 ·Psychopharmacology ·R.M. Hagan, Gavin J. Kilpatrick, M.B. Tyers	45
3	7 Ondansetron and Related 5-HT3 Antagonists: Recent Advances 1992 ·Progress in medicinal chemistry ·A. W. Oxford, (unknown), Gavin J. Kilpatrick, S.J. Ireland, M.B. Tyers	24
4	Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset 1992 ·Pharmacology Biochemistry and Behavior ·Galen Carey, B. Costall, A.M. Domeney, Philip Gerrard, (unknown), R.J. Naylor, M.B. Tyers	51
5	The Role of 5-HT in Postoperative Nausea and Vomiting 1992 ·British Journal of Anaesthesia ·K T Bunce, M.B. Tyers	68
6	Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat 1992 ·Drug and Alcohol Dependence ·Jon D. Lane, Chris Pickering, M. Hooper, Karen Fagan, M.B. Tyers, M. W. Emmett‐Oglesby	56
7	The pharmacology of fluparoxan: a selective α₂‐adrenoceptor antagonist 1991 ·British Journal of Pharmacology ·(unknown), Brian Jones, M. Skingle, (unknown), Helen Wise, M.B. Tyers	25
8	The pharmacological characterization of 5‐HT₃ receptors in three isolated preparations derived from guinea‐pig tissues 1990 ·British Journal of Pharmacology ·(unknown), (unknown), Jane M. Burridge, S.J. Ireland, K T Bunce, Gavin J. Kilpatrick, M.B. Tyers	90
9	A series of novel, highly potent and selective agonists for the κ‐opioid receptor 1990 ·British Journal of Pharmacology ·Ann G. Hayes, P.J. Birch, Neil J. Hayward, Michael J. Sheehan, H. L. Rogers, M.B. Tyers, Duncan B. Judd, D. I. C. SCOPES, Alan Naylor	30
10	5‐HT₃ Receptors 1990 ·Annals of the New York Academy of Sciences ·M.B. Tyers	27
11	[3H] GR67330, a very high affinity ligand for 5-HT3 receptors 1990 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Gavin J. Kilpatrick, (unknown), R.M. Hagan, Brian Jones, M.B. Tyers	25
12	Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse 1990 ·Pharmacology Biochemistry and Behavior ·B. Costall, Brian Jones, M.E. Kelly, R.J. Naylor, E.S. Onaivi, M.B. Tyers	100
13	Sites of action of ondansetron to inhibit withdrawal from drugs of abuse 1990 ·Pharmacology Biochemistry and Behavior ·B. Costall, Brian Jones, M.E. Kelly, R.J. Naylor, E.S. Onaivi, M.B. Tyers	87
14	5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue 1989 ·Nature ·Janine M. Barnes, Nicholas M. Barnes, B. Costall, R.J. Naylor, M.B. Tyers	214
15	The potential anxiolytic activity of GR38032F, a 5‐HT₃‐receptor antagonist 1988 ·British Journal of Pharmacology ·Brian J. Jones, B. Costall, A.M. Domeney, M.E. Kelly, R.J. Naylor, N.R. Oakley, M.B. Tyers	282
16	Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding breakdown → 1987 ·Nature ·Gavin J. Kilpatrick, Brian Jones, M.B. Tyers	746
17	Effects of the 5‐HT₃ receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain 1987 ·British Journal of Pharmacology ·B. Costall, A.M. Domeney, R.J. Naylor, M.B. Tyers	306
18	Differential sensitivity of models of antinociception in the rat, mouse and guinea‐pig to μ‐and κ‐opioid receptor agonists 1987 ·British Journal of Pharmacology ·Ann G. Hayes, Michael J. Sheehan, M.B. Tyers	96
19	Proceedings: AH 10407: a novel, short-acting, competitive neuromuscular blocking drug in animals and man. 1975 ·British Journal of Pharmacology ·C. E. BLOGG, R T Brittain, B. R. Simpson, M.B. Tyers	1
20	Proceedings: Evaluation of narcotic and narcotic antagonist analgesic drugs in the dog dental pulp stimulation test. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·A.S. Marriott, M. Skingle, M.B. Tyers	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact